W e are taught in medical school to use comorbidities to help frame our understanding of the patient under our care. Many healthcare providers instinctively view a high body mass index (BMI) as a factor that may negatively impact a patient's long-term health trajectory and certainly one that predicts a difficult course if seriously ill in the ICU. For example, obesity appears to be a true comorbidity for those who contract influenza (1) . But, consistently, accumulating data suggest that in the general context of critical illness, obesity may have a protective effect in the shortterm-the "obesity paradox" (2, 3). Less well understood are the consequences of obesity for patients who are recovering after hospital discharge. There are several (unproven) reasons to assume obese patients might have higher mortality and more difficulties. For example, obese patients may struggle to participate in physical therapy, which appears to help decrease long-term mortality (4); obesity may complicate wound healing for abdominal or other wounds; or it may make individuals more susceptible to atelectasis and pneumonia because of lower thoracic compliance.
In this issue of Critical Care Medicine, Prescott et al (5) provide data from a 1-year mortality and resource study of obese patients (vs normal weight) who were admitted to the hospital with severe sepsis. They report that the adjusted odds of death at 1 year after hospital discharge for obese patients was half that of normal weight patients-an effect present across all ages and obesity classes (5). The authors made use of the Health and Retirement Study (HRS), an ongoing, nationally representative, cohort study of older Americans that includes information on health and functional status and also allows for linkage with Medicare data to provide information on hospitalizations and healthcare resource use. One great strength of the HRS is the ability to have information on a person before a critical illness (6), and especially important for this study is the availability of height and weight estimates. In their cohort of 1,404 people hospitalized with severe sepsis, 50% were admitted to an ICU and 25-30% received mechanical ventilation. For those who survived to hospital discharge (n = 1,087), the 1-year mortality ranged from a high of 62.0% for normal weight patients (BMI, 18.5-24.9) down to 44.7% for severely obese patients (BMI, ≥ 35.0). Although functional disability was more prevalent in the obese population before sepsis, there was no increase in limitations in this group after sepsis relative to other groups.
The data on healthcare utilization were more complex. Previous studies have been mixed as to whether obese patients "use" more healthcare resources when critically ill (2). Again, counter to general assumptions, healthcare utilization before hospitalizations in this study was no greater for patients with higher BMI. After the hospitalization, obese patients had more hospital readmissions and spent more days admitted to an inpatient facility. However, this finding was explained by the fact that obese patients survived for longer and therefore had more time to use these resources.
Although they adjusted for known differences between groups, the authors recognize that not all sepsis is created equal. For example, patients with higher BMI were more likely to have renal injury as their sepsis-defining organ dysfunction (5), and it is known that such patients tend to have better outcomes (7), raising the concern of residual confounding. Additionally, obese patients may have been treated differently because of their size or the cause of their sepsis (3), and it is possible that some of the mortality reduction may be attributable to such sepsis-associated differences. However, as the findings of this article are in line with other data from intensive care, and from broader general population cohorts (8, 9), it is unlikely that all of the mortality difference may be accounted for by differences in sepsis or treatment.
These data provide important information about long-term outcomes after critical illness but still cannot tell us "why" obesity continues to exert protection in the short-or long-term. While still an alarming number, less than 25% of the patients hospitalized with severe sepsis were classified as obese. Given the continued risk of death associated with severe sepsis and septic shock-over 60% of normal weight patients were dead by the end of 1 year-perhaps, we can use these important findings as a springboard to determine the beneficial mechanisms associated with additional body weight and ultimate "protect" all those with sepsis. At the very least, this study adds to the compelling evidence that it may be time to remove obesity from the top of the comorbidities list in the ICU and after hospital discharge. Raised Intracranial Pressure During CNS Infection: What Should We Do About It?* N ormal cerebrospinal fluid (CSF) pressure in children at the time of lumbar puncture is positive in relation to atmospheric pressure, with 10th-90th percentile of 11.5-28 cm H 2 O or 8.7-21.2 mm Hg, respectively (1). Intracranial pressure (ICP) is the pressure of CSF inside the cerebral ventricles, which is determined by cerebral blood flow (CBF) and CSF circulation. The Davson equation describes this relationship and states that ICP is the sum of sagittal sinus pressure and the product of CSF formation rate and resistance to CSF outflow (2). Normal values for sagittal sinus pressure, CSF formation rate, and resistance to CSF outflow are 5-8 mm Hg, 0.3-0.4 mL/min, and 6-10 mm Hg/mL/min, respectively. Measured ICP is often greater than the calculated value because of a vascular component, which is probably a result of pulsation in the arterial bed and the interaction between pulsatile arterial inflow and venous outflow curves, cardiac function, and cerebral vasomotor tone (3). All of these interrelationships may be altered in critically ill comatose patients with CNS infection.
These abnormalities may also be compounded by brain swelling, edema and increased cerebral blood volume (CBV), focal cerebral perfusion deficits and variable levels of CBF and cerebrovascular CO 2 reactivity, and cerebral vasculitis (4-7). The net result is raised ICP along with significant risk of brain tissue herniation and ischemic syndromes and death (8-10).
In this issue of Critical Care Medicine, Kumar et al (11) report a study from Chandigarh, India, in comatose children (aged 1-12 yr) with acute CNS infection undergoing invasive ICP monitoring. The authors addressed the pragmatic question of whether to target level of ICP (< 20 mm Hg) or whether to target level of cerebral perfusion pressure (CPP > 60 mm Hg, the difference between mean arterial blood pressure [BP] and mean ICP) with ICU therapies. The authors' conclusion from this randomized controlled trial (RCT) is that the CPP goal, rather than ICP goal, is superior and results in better rates of morbidity and mortality. This study has significant bearing on both adult and pediatric critical care practice. However, there are important considerations that warrant further discussion.
First, there were major therapeutic consequences of the different strategies used in this RCT. The primary aim of targeting level of CPP meant that systolic BP was targeted to the 95th percentile for age, and hence, there was more frequent use of inotropes. The primary aim of targeting level of ICP meant that any systolic BP more than 5th percentile was considered acceptable, and as a consequence, these patients had lower BP. In addition, the ICP group was exposed to hyperventilation and osmotherapy more frequently than the CPP group. At the start of experimental interventions, both groups had similar level of mean BP, around the 90th percentile for age. Yet, over subsequent hours, the ICP group had mean BP that decreased to the 50th percentile, whereas the CPP group had mean BP that increased to the 95th percentile. Over this same period, the mean ICP in all patients fell to a level within the normal range (1), albeit lower in the ICP group. We need to learn more from these observations by Kumar et al (11) and what they tell us about life-threatening CNS infection. For example, in relation
